Literature DB >> 14698629

Production of recombinant serpins in Escherichia coli.

Phillip I Bird1, Stephen C Pak, D Margaret Worrall, Stephen P Bottomley.   

Abstract

Expression systems based on Escherichia coli offer fast, cheap, and convenient means for the production of recombinant serpins. Over 30 active serpins from prokaryotic and eukaryotic organisms have been produced in this way, using a variety of vectors, promoters, fusion partners, and host strains. Serpins forming insoluble inclusion bodies in E. coli can generally be solubilized and refolded. Here, we outline the general approaches and procedures to be considered when contemplating the use of E. coli for recombinant serpin production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698629     DOI: 10.1016/s1046-2023(03)00208-1

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  9 in total

1.  Preventing serpin aggregation: the molecular mechanism of citrate action upon antitrypsin unfolding.

Authors:  Mary C Pearce; Craig J Morton; Susanne C Feil; Guido Hansen; Julian J Adams; Michael W Parker; Stephen P Bottomley
Journal:  Protein Sci       Date:  2008-09-09       Impact factor: 6.725

2.  Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli.

Authors:  Suryakala Sarilla; Sally Y Habib; Douglas M Tollefsen; David B Friedman; Diana R Arnett; Ingrid M Verhamme
Journal:  Anal Biochem       Date:  2010-07-27       Impact factor: 3.365

3.  Lactobacillus plantarum and Lactobacillus buchneri as expression systems: evaluation of different origins of replication for the design of suitable shuttle vectors.

Authors:  Katharina Spath; Stefan Heinl; Esther Egger; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

4.  A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production.

Authors:  Lisa D Cabrita; Weiwen Dai; Stephen P Bottomley
Journal:  BMC Biotechnol       Date:  2006-03-01       Impact factor: 2.563

5.  A dynamic method for the investigation of induced state metabolic capacities as a function of temperature.

Authors:  Patrick Sagmeister; Timo Langemann; Patrick Wechselberger; Andrea Meitz; Christoph Herwig
Journal:  Microb Cell Fact       Date:  2013-10-15       Impact factor: 5.328

6.  Escherichia coli-based production of recombinant ovine angiotensinogen and its characterization as a renin substrate.

Authors:  Shinji Yamashita; Naoya Shibata; Akiyoshi Boku-Ikeda; Erika Abe; Ayumi Inayama; Takashi Yamaguchi; Ayano Higuma; Kaoru Inagaki; Tomoyo Tsuyuzaki; Satoshi Iwamoto; Satoshi Ohno; Takashi Yokogawa; Kazuya Nishikawa; Kazal Boron Biswas; A H M Nurun Nabi; Tsutomu Nakagawa; Fumiaki Suzuki; Akio Ebihara
Journal:  BMC Biotechnol       Date:  2016-04-07       Impact factor: 2.563

7.  A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.

Authors:  Daniela Ehgartner; Patrick Sagmeister; Timo Langemann; Andrea Meitz; Werner Lubitz; Christoph Herwig
Journal:  Appl Microbiol Biotechnol       Date:  2017-04-20       Impact factor: 4.813

8.  Mining a differential sialotranscriptome of Rhipicephalus microplus guides antigen discovery to formulate a vaccine that reduces tick infestations.

Authors:  Sandra R Maruyama; Gustavo R Garcia; Felipe R Teixeira; Lucinda G Brandão; Jennifer M Anderson; José M C Ribeiro; Jesus G Valenzuela; Jana Horackova; Cecília J Veríssimo; Luciana M Katiki; Tamy M Banin; Amanda F Zangirolamo; Luiz G Gardinassi; Beatriz R Ferreira; Isabel K F de Miranda-Santos
Journal:  Parasit Vectors       Date:  2017-04-26       Impact factor: 3.876

9.  Catechol biosynthesis from glucose in Escherichia coli anthranilate-overproducer strains by heterologous expression of anthranilate 1,2-dioxygenase from Pseudomonas aeruginosa PAO1.

Authors:  Víctor E Balderas-Hernández; Luis G Treviño-Quintanilla; Georgina Hernández-Chávez; Alfredo Martinez; Francisco Bolívar; Guillermo Gosset
Journal:  Microb Cell Fact       Date:  2014-10-04       Impact factor: 5.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.